A phase I study of the histone deacetylase (HDAC) inhibitor entinostat, in combination with sorafenib in patients with advanced solid tumors
Ngamphaiboon, Nuttapong, Dy, Grace K., Ma, Wen Wee, Zhao, Yujie, Reungwetwattana, Thanyanan, DePaolo, Dawn, Ding, Yi, Brady, William, Fetterly, Gerald, Adjei, Alex A.Volume:
33
Langue:
english
Journal:
Investigational New Drugs
DOI:
10.1007/s10637-014-0174-6
Date:
February, 2015
Fichier:
PDF, 466 KB
english, 2015